Skip to main content

Table 1 Baseline Vitiligo European Task Force characteristics of participants starting treatment

From: Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial

Sex

 

Female

8

Male

4

Mean Years of Age (range)

18 (12-29)

Fitzpatrick's phototypes

 

   I

1

   II

0

   III

0

   IV

2

   V

9

   VI

0

Duration of disease, mean years (range)

5.96 (2-17)

Ethnicity

 

   Caucasian

2

   South Asian

9

   South American

1

Disease activity

 

   Progressive

7

   Non progressive

5

Previous repigmentation

 

   after treatment

11

   spontaneous

0

   no repigmentation

1

Depigmentation on scars

5

Stress at onset

2

Stress as precipitating factor

2

Itch before lesions

3

Vitiligo on genitals

3

Thyroid disease

 

   Yes

1

   No

11

Thyroid antibodies

 

   Yes

0

   No

9

   unknown

3

Family history of premature gray hair

4

Family history of vitiligo

3

Degree to which vitiligo affects everyday life (out of 10, 10 being the worst) (SD)

3.7 (1.84)

History of autoimmune disease

0

Family history of thyroid or other autoimmune disease

1

Halo Nevus

0

  1. n = 12, SD = standard deviation.